Microplastics refer to plastic particles with a diameter less than 5 mm. Based on their source, they can be classified as primary microplastics, such as abrasive particles in toothpaste and facial cleansers, and secondary microplastics formed from the environmental degradation and fragmentation of plastic products. In recent years, with the extensive use and improper disposal of plastic products, microplastics have become a global environmental pollution issue.
These ubiquitous microplastics can enter the human body through various pathways, including inhalation, diet, and daily use products. Studies indicate that an average of 325 microplastic particles can be detected per liter of bottled water, and urban residents may inhale approximately 32,000 microplastic particles annually through respiration[1]. These invading microplastics can further breach various biological barriers in the human body, widely existing in blood, brain, liver, kidneys, placenta, and other organs, where they can persistently accumulate[2].
Fig 1. The spread of microplastics
Simultaneously, microplastics can act as carriers, adsorbing toxic substances such as heavy metals and organic pollutants, forming composite pollutants that exacerbate their biological toxicity to humans[3]. Epidemiological data suggests that microplastic exposure is associated with various human health risks, including gastrointestinal inflammation, abnormal immune responses, and tumors[4]. Notably, microplastics can also affect sperm motility[5] and can be transferred to fetuses via the placenta, indicating their potential for transgenerational health effects[6].
Since the environmental pollution problem of microplastics cannot be completely resolved, we are focusing on the human gut. We aim to employ synthetic biology strategies to design and develop an engineered yeast-based microplastic degradation system. This system is intended to specifically recognize, adsorb, and degrade microplastics within the human intestinal tract, while also repairing intestinal mucosal damage caused by microplastics. The goal is to minimize the accumulation of microplastics in the human body and their potential health risks, offering a novel biological remediation strategy to address the global health challenges posed by microplastic pollution[7].